Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells

International Journal of Cancer

Volumn 97, Issue 5, 2002, Pages 621-625

  Suenaga, Mitsuhiro ^a,b   Soda, Hiroshi ^b   Oka, Mikio ^b   Yamaguchi, Akihiko ^a   Nakatomi, Katsumi ^b   Shiozawa, Ken ^b   Kawabata, Shigeru ^b   Kasai, Takashi ^b   Yamada, Yasuaki ^b   Kamihira, Shimeru ^b   Tei, Chuwa ^a   Kohno, Shigeru ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Androgen; Histone deacetylase inhibitor; Prostate cancer; Telomerase

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; MYC PROTEIN; PROTEIN P21; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; CANCER CELL; CATALYSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

BUTYRATES; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MALE; NEOPLASMS, EXPERIMENTAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0037050728     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10082     Document Type: Article

References (26)

1. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
2. Inhibition of histone deacetylases: A new strategy to target epigenetic modifications for anticancer treatment
3. Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers
4. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors
5. Preclinical and clinical strategies for development of telomerase and telomere inhibitors
6. Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro
7. Telomeres, telomerase and cancer: An up-date
8. Direct activation of TERT transcription by c-MYC
9. The human telomerase catalytic subunit in hTERT: Organization of the gene and characterization of the promoter
10. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway
11. Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus
12. Nucleophosmin/B23 regulates the susceptibility of human leukemia HL-60 cells to sodium butyrate-induced apoptosis and inhibition of telomerase activity
13. A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: Implications for radiosensitization and EBV-targeted therapy
14. Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines
15. Carboxypeptidase A3 (CPA3): A novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells
16. Telomerase catalytic subunit homologs from fission yeast and human
17. Effect of prostate biopsy on the results of the PSA RT-PCR test
18. 1- and bax-α-mediated regulation of apoptosis of human neutrophils via caspase-3
19. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: Regulatory mechanisms
20. Stem cell genes in androgen-independent prostate cancer
21. Sodium butyrate inhibits histone deacetylation in cultured cells
22. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts
23. Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT
24. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
25. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues
26. htert expression correlates with MYC over-expression in human prostate cancer